Wednesday, October 22, 2014
Inquirer Daily News

Breast Cancer

  • More Top Stories
  • Latest News
Proper diet, exercise, weight control among factors that may help, experts say
With arrival of October comes plenty of pink on everything everywhere as part of Breast Cancer Awareness Month. So what better time to raise awareness about what’s helpful — and what’s not — when a friend, family member or acquaintance has cancer?
Study finds notable rise in number of women once considered at high risk for the procedure
Ten years ago, after successful treatment for breast cancer, anxiety became Susan Chase's constant companion. She was unable to sleep, and the unsettled feeling that "the sky was going to fall on me" plagued her daily life.
Contrary to media reports, researchers found no evidence wearing them boosted chances of disease
Drug should remain standard of care for HER2-positive tumors, doctors say
For some women with breast cancer, taking soy protein supplements boosted the expression of tumor genes associated with an increase in tumor cells.
Vicki Wolf was only 36 when she was first diagnosed with early-stage breast cancer. After her third diagnosis 11 years later, the native Philadelphian had a genetic test that revealed what she dreaded and expected: She had inherited a mutation in a gene that made her susceptible to the disease.
A new statistical analysis finds that women under age 50 who were diagnosed with breast cancer were also more likely to have recently been on some versions of the Pill.
Genetic variation also linked to less dense tissue
Taking drug in addition to chemotherapy also reduces risk of cancer recurrence
Proper diet, exercise, weight control among factors that may help, experts say
'Extra Help' program leads to more women on hormone therapy, study reports
Mastectomy patients benefit from lidocaine, study says
Breast cancer particularly troubling, researchers report
Study finds notable rise in number of women once considered at high risk for the procedure
Tumors in rodents exposed to dim light seemed to develop resistance to a common cancer drug
Tumors in rodents exposed to dim light seemed to develop resistance to a common cancer drug
Finding is yet another reason to maintain a healthy weight, experts say
Drug should remain standard of care for HER2-positive tumors, doctors say
Tumors in rodents exposed to dim light seemed to develop resistance to a common cancer drug
Women with HER2-positive tumors gained an average 16 more months of life with Perjeta, study finds
Finding was specific to tough-to-treat estrogen receptor-negative tumors, researchers say